PHARMACEUTICAL ECONSULTING A/S: Financial statements 2014
CVR: 30815378
Source: annual report 2014, Danish Business Authority
01/10/2013 – 30/09/2014
PHARMACEUTICAL ECONSULTING A/S (CVR 30815378) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2014 report amounted to DKK 0.
- Profit/Loss
- DKK 0
- Equity
- DKK 0
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | - | 0 | 0 | - |
| 2013 | - | - | 0 | 0 | - |
| 2012 | - | -1.8 mio. | 397 t. | -1.3 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2013. The net result was DKK 0.
As of April 2, 2014, Optimal Revision Godkendt Revisionsvirksomhed has stepped down as auditor of PHARMACEUTICAL ECONSULTING A/S.
About PHARMACEUTICAL ECONSULTING A/S
PHARMACEUTICAL ECONSULTING A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2007. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Steen Otto Rugaard. The board consists of Pernille Laurberg Rugaard (chair), Hanne Laurberg Olesen and Steen Otto Rugaard. The company is owned by RUGAARD HOLDING ApS. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 6,113,709 and a net result of DKK -1,066,960 compared with DKK -643,853 the year before. Equity in the 2025 report amounted to DKK 5,152,605.